clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Multimedia
eBooks
Webinars
Virtual Events
Learning Labs
Podcasts
Inside Precision Medicine Live
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Blood Disorders
Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy
Coronavirus
Study Defines Four Distinct Phenotypes of Long COVID
Lung Cancer
Tagrisso Doubles Survival Rate in EGFR Positive Lung Cancer
News & Features
Rare Mutations Confer Risk of Common Diseases
Molecular Dx
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial…
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Multimedia
eBooks
Webinars
Virtual Events
Learning Labs
Podcasts
Inside Precision Medicine Live
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Companies
Merck & Co
Merck & Co
Antivirals
Merck Discontinues Development of 2 COVID-19 Vaccines
January 25, 2021
0
AstraZeneca
FDA Approves Myriad BRACAnalysis CDx for Lynparza in Metastatic Pancreatic Cancer
December 30, 2019
0
Companies
Promega to Develop MSI Technology as CDx to Merck’s Keytruda
November 6, 2019
0
AstraZeneca
Myriad to Pursue mCRPC Approval for BRACAnalysis CDx
August 7, 2019
0
AstraZeneca
Myriad Genetics Expands CDx Collaboration with AstraZeneca, Merck & Co.
April 4, 2019
0
Business
FDA Grants Priority Review for Keytruda in SCLC
February 20, 2019
0
Applications
Merck Using PGDx Pan-Cancer Tissue Assay in Combination Therapy Trial
January 3, 2019
0
Agilent Technologies
Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer
June 13, 2018
0
Business
Merck Taps Foundation Medicine for Keytruda CDx Development
May 24, 2018
0
Applications
Illumina Ventures, Merck Among Investors as SerImmune Raises $8M
June 21, 2017
0
1
2
Page 1 of 2
Trending
Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy
June 5, 2023
Study Defines Four Distinct Phenotypes of Long COVID
June 5, 2023
Rare Mutations Confer Risk of Common Diseases
June 2, 2023
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching
June 2, 2023
Inside Precision Medicine
